Antihyperlipidemic effect of tyrosol, a phenolic compound in streptozotocin-induced diabetic rats

References

• Ahn EY, Jiang Y, Zhang Y, Son EM, You S, Kang SW, Park JS, Jung JH, Lee BJ, Kim DK. 2008. Cytotoxicity of p-tyrosol and its derivatives may correlate with the inhibition of DNA replication initiation. Oncol Rep. 19:527–534.
   PubMed Web of Science ®Google Scholar
• Alves-Bezerra M, Cohen DE. 2017. Triglyceride metabolism in the liver. Compr Physiol. 8:1–8.
   PubMed Web of Science ®Google Scholar
• Amor AJ, Catalan M, Perez A, Herreras Z, Pinyol M, Sala-Vila A, Cofan M, Gilabert R, Ros E, Ortega E. 2016. Nuclear magnetic resonance lipoprotein abnormalities in newly-diagnosed type 2 diabetes and their association with preclinical carotid atherosclerosis. Atherosclerosis. 247:161–169.
   PubMed Web of Science ®Google Scholar
• Arcari DP, Porto VB, Rodrigues ERV, Martins F, Lima RJD, Sawaya ACHF, Ribeiro ML, Carvalho PDO. 2011. Effect of mate tea (Ilex paraguariensis) supplementation on oxidative stress biomarkers and LDL oxidisability in normo- and hyperlipidaemic humans. J Funct Foods. 3(3):190–197.
   Web of Science ®Google Scholar
• Bu Y, Rho S, Kim J, Kim MY, Lee DH, Kim SY, Choi H, Kim H. 2007. Neuroprotective effect of tyrosol on transient focal cerebral ischemia in rats. Neurosci Lett. 414(3):218–221.
   PubMed Web of Science ®Google Scholar
• Camont L, Chapman MJ, Kontush A. 2011. Biological activities of HDL subpopulations and their relevance to cardiovascular disease. Trends Mol Med. 17(10):594–603.
   PubMed Web of Science ®Google Scholar
• Caruso D, Berra B, Giavarini F, Cortesi N, Fedeli E, Galli G. 1999. Effect of virgin olive oil phenolic compounds on in vitro oxidation of human low density lipoproteins. Nutr Metab Cardiovasc Dis. 9:102–107.
   PubMed Web of Science ®Google Scholar
• Chandramohan R, Pari L. 2016. Anti-inflammatory effects of tyrosol in streptozotocin-induced diabetic Wistar rats. J Funct Foods. 27:17–28.
   Web of Science ®Google Scholar
• Chandramohan R, Pari L, Rathinam A, Sheikh BA. 2015. Tyrosol, a phenolic compound, ameliorates hyperglycemia by regulating key enzymes of carbohydrate metabolism in streptozotocin induced diabetic rats. Chem Biol Interact. 229:44–54.
   PubMed Web of Science ®Google Scholar
• Chandramohan R, Saravanan S, Pari L. 2017. Beneficial effects of tyrosol on altered glycoprotein components in streptozotocin induced diabetic rats. Pharm Biol. 55(1):1631–1637.
   PubMedGoogle Scholar
• Chen WP, Chi TC, Chuang LM, Su MJ. 2007. Resveratrol enhances insulin secretion by blocking K (ATP) and K(V) channels of beta cells. Eur J Pharmacol. 568(1-3):269–277.
   PubMed Web of Science ®Google Scholar
• Coni E, Di Benedetto R, Di Pasquale M, Masella R, Modesti D, Mattei R, Carlini EA. 2000. Protective effect of oleuropein, and olive oil biophenol, on low density lipoprotein oxidizability in rabbits. Lipids. 35(1):45–54.
   PubMed Web of Science ®Google Scholar
• Correa JAG, Lopez-Villodres JA, Asensi R, Espartero JL, Rodriguez-Gutierez G, Cruz JPDL. 2008. Virgin olive oil polyphenol hydroxytyrosol acetate inhibits in vitro platelet aggregation in human whole blood: comparison with hydroxytyrosol and acetylsalicylic acid. Br J Nutr. 101(8):1157–1164.
   PubMed Web of Science ®Google Scholar
• Covas MI, Fito M, Lamuela-Raventos RM, Sebastia N, Torre-Boronat CDL, Marrugat J. 2000. Virgin olive oil phenolic compounds: binding to human LDL and effect on LDL oxidation. Int J Clin Pharmacol Res. 20:49–54.
   PubMedGoogle Scholar
• Dawaliby R, Trubbia C, Delporte C, Noyon C, Ruysschaert JM, Antwerpen PV, Govaerts C. 2016. Phosphatidylethanolamine is a key regulator of membrane fluidity in eukaryotic cells. J Biol Chem. 291(7):3658–3667.
   PubMed Web of Science ®Google Scholar
• Falholt K, Lund B, Falholt W. 1973. An easy colorimetric micromethod for routine determination of free fatty acids in plasma. Clin Chim Acta. 46(2):105–111.
   PubMed Web of Science ®Google Scholar
• Farbstein D, Levy AP. 2012. HDL dysfunction in diabetes: causes and possible treatments. Expert Rev Cardiovasc Ther. 10(3):353–361.
   PubMedGoogle Scholar
• Folch J, Lees M, Sloane Stanley GH. 1957. A simple method for the isolation and purification of total lipides from animal tissues. J Biol Chem. 226(1):497–509.
   PubMed Web of Science ®Google Scholar
• Fossati P, Prencipe L. 1982. Serum triglycerides determined colorimetrically with an enzyme that produces hydrogen peroxide. Clin Chem. 28(10):2077–2080.
   PubMed Web of Science ®Google Scholar
• Hegarty BD, Furler SM, Ye J, Cooney GJ, Kraegen EW. 2003. The role of intramuscular lipid in insulin resistance. Acta Physiol Scand. 178(4):373–383.
   PubMedGoogle Scholar
• Hirano T. 2018. Pathophysiology of diabetic dyslipidemia. J Atheroscler Thromb. 25(9):771–782.
   PubMed Web of Science ®Google Scholar
• Hitz J, Steinmetz J, Siest G. 1983. Plasma lecithin: cholesterol acyltransferase – reference values and effects of xenobiotics. Clin Chim Acta. 133(1):85–96.
   PubMed Web of Science ®Google Scholar
• International Diabetes Federation 2019. Diabetes atlas. 9th ed. https://www.diabetesatlas.org/en/resources/.
   Google Scholar
• Kalaivani K, Sankaranarayanan C. 2019. Isopulegol ameliorates dyslipidemia by modulating adipokine secretion in high fat diet/streptozotocin induced diabetic rats. J Drug Deliv Ther. 9(4-A):126–136.
   Google Scholar
• Korn ED. 1955. Clearing factor, a heparin-activated lipoprotein lipase: I. Isolation and characterization of the enzyme from normal rat heart. J Biol Chem. 215(1):1–14.
   PubMed Web of Science ®Google Scholar
• Kripa K, Vijayalakshmi NR, Helen A. 2011. Methanolic extract of costusigneus (N.E.Br.) alleviates dyslipidemia in diabetic rats. Asian J Pharm Clin Res. 4:154–157.
   Google Scholar
• Loru D, Incani A, Deiana M, Corona G, Atzeri A, Melis MP, Rosa A, Dessi MA. 2009. Protective effect of hydroxytyrosol and tyrosol against oxidative stress in kidney cells. Toxicol Ind Health. 25(4-5):301–310.
   PubMed Web of Science ®Google Scholar
• Oates JA, Wood AJJ, Gerich JE. 1989. Oral hypoglycemic agents. N Engl J Med. 321(18):1231–1245.
   PubMed Web of Science ®Google Scholar
• Owen RW, Giacosa A, Hull WE, Haubner R, Spiegelhalder B, Bartsch H. 2000. The antioxidant/anticancer potential of phenolic compounds isolated from olive oil. Eur J Cancer. 36(10):1235–1247.
   PubMed Web of Science ®Google Scholar
• Pari L, Chandramohan R. 2015. Beneficial effects of tyrosol on plasma lipid peroxidation and non-enzymatic antioxidants in streptozotocin induced diabetic rats. IAJMR. 1:205–212.
   Google Scholar
• Pari L, Rajarajeswari N, Saravanan S, Rathinam A. 2014. Antihyperlipidemic effect of coumarin in experimental type 2 diabetic rats. Biomed Prev Nutr. 4(2):171–176.
   Google Scholar
• Philipp BW, Shapiro DJ. 1979. Improved methods for the assay and activation of 3-hydroxy-3-methylglutaryl coenzyme A reductase. J Lipid Res. 20(5):588–593.
   PubMed Web of Science ®Google Scholar
• Piñeiro Z, Cantos-Villar E, Palma M, Puertas B. 2011. Direct liquid chromatography method for the simultaneous quantification of hydroxytyrosol and tyrosol in red wines. J Agric Food Chem. 59(21):11683–11689.
   PubMed Web of Science ®Google Scholar
• Prenner SB, Mulvey CK, Ferguson JF, Rickels MR, Bhatt AB, Reilly MP. 2014. Very low density lipoprotein cholesterol associates with coronary artery calcification in type 2 diabetes beyond circulating levels of triglycerides. Atherosclerosis. 236(2):244–250.
   PubMed Web of Science ®Google Scholar
• Ramesh B, Karuna R, Sreenivasa Reddy S, Sudhakara G, Saralakumari D. 2013. Ethanolic extract of commiphoramukul gum resin attenuates streptozotocin-induced alterations in carbohydrate and lipid metabolism in rats. Excli J. 12:556–568.
   PubMed Web of Science ®Google Scholar
• Sankaranarayanan C, Pari L. 2011. Thymoquinone ameliorates chemical induced oxidative stress and β-cell damage in experimental hyperglycemic rats. Chem Biol Interact. 190(2-3):148–154.
   PubMed Web of Science ®Google Scholar
• Sarfraz M, Sajid S, Ashraf MA. 2016. Prevalence and pattern of dyslipidemia in hyperglycemic patients and its associated factors among Pakistani population. Saudi J Biol Sci. 23(6):761–766.
   PubMed Web of Science ®Google Scholar
• Serrano-Martín X, Payares G, Mendoza-León A, 2006. Glibenclamide, a blocker of K+ (ATP) channels, shows antileishmanial activity in experimental murine cutaneous leishmaniasis. AAC. 50(12):4214–4216.
   Google Scholar
• Srinivasan S, Pari L. 2013. Antihyperlipidemic effect of diosmin: A citrus flavonoid on lipid metabolism in experimental diabetic rats. J Funct Foods. 5(1):484–492.
   Web of Science ®Google Scholar
• Stefano DD, Maiuri MC, Simeon V, Grassia G, Soscia A, Cinelli MP, Carnuccio R. 2007. Lycopene, quercetin and tyrosol prevent macrophage activation induced by gliadin and IFN-gamma. Eur J Pharmacol. 566(1-3):192–199.
   PubMed Web of Science ®Google Scholar
• Sujithra K, Subramani S, Dhananjayan I, Vinothkumar V. 2019. Allyl methyl sulfide, a garlic active component mitigates hyperglycemia by restoration of circulatory antioxidant status and attenuating glycoprotein components in streptozotocin-induced experimental rats. Toxicol Mech Methods. 29(3):165–176.
   PubMed Web of Science ®Google Scholar
• Suzuki T, Sawada S, Ishigaki Y, Tsukita S, Kodama S, Sugisawa T, Imai J, Yamada T, Yamaguchi T, Murano T, et al. 2016. Lipoprotein lipase deficiency (R243H) ina type 2 diabetes patient with multiple arterial aneurysms. Intern Med. 55(9):1131–1136.
   PubMed Web of Science ®Google Scholar
• Trinder P. 1969. Determination of glucose in blood using glucose oxidase with an alternative oxygen acceptor. Ann Clin Biochem. 6(1):24–27.
   Google Scholar
• Tsoupras A, Lordan R, Zabetakis I. 2018. Inflammation, not cholesterol, is a cause of chronic disease. Nutrients. 10(5):604.
   Web of Science ®Google Scholar
• Tuck KL, Freeman MP, Hayball PJ, Stretch GL, Stupans I. 2001. The in vivo fate of hydroxytyrosol and tyrosol, antioxidant phenolic constituents of olive oil, after intravenous and oral dosing of labeled compounds to rats. J Nutr. 131(7):1993–1996.
   PubMed Web of Science ®Google Scholar
• Vergès B. 2015. Pathophysiology of diabetic dyslipidaemia: where are we? Diabetologia. 58(5):886–899.
   PubMed Web of Science ®Google Scholar
• Wu L, Parhofer KG. 2014. Diabetic dyslipidemia. Metab Clin Exp. 63(12):1469–1479.
   PubMed Web of Science ®Google Scholar
• Young SG, Zechner R. 2013. Biochemistry and pathophysiology of intravascular and intracellular lipolysis. Genes Dev. 27(5):459–484.
   PubMed Web of Science ®Google Scholar
• Zilversmit DB, Davis AK. 1950. Microdetermination of plasma phospholipids by trichloroacetic acid precipitation. J Lab Clin Med. 35:155–160.
   PubMed Web of Science ®Google Scholar
• Zlatkis A, Zak B, Boyle AJ. 1953. A new method for the direct determination of serum cholesterol. J Lab Clin Med. 41:486–492.
   PubMed Web of Science ®Google Scholar
• Zunkler BJ, Lenzen S, Manner K, Panten U, Trube G. 1988. Concentrationdependent effects of tolbutamide, meglitinide, glipizide, glibenclamide and diazoxide on ATP-regulated K + currents in pancreatic B-cells. Arch Pharmacol. 337:225–230.
   Google Scholar